Newsletter 42/2018
If you are having trouble viewing this e-mail, please click here.
Issue #1018
Top Articles
Perspectives from the Bench
World leader in IOL research, Liliana Werner, discusses the potential of adjustable lens technologies.
Unlock the Surrogates
Could molecular biomarkers mean better outcomes for glaucoma patients? Rajendra S. Apte explains why he thinks they could help with diagnosis and monitoring.
Printed Vision
Researchers at the University of Minnesota are the first to fully 3D-print a ‘bionic eye’ – a hemispherical photodetector array made of five material layers.
Our In My View section features experts from around the world sharing their viewpoints on important subjects in ophthalmology. Do you have a strongly-held opinion or key idea you’d like to share? To submit an article and join the conversation, simply contact
Targeting CSCR with Navigated Laser
The webinar ‘Targeting CSCR with Navigated Laser’ by OD-OS takes place on November 7, 2018 at 17:30 pm CST. Have you registered to attend?
Product Profiles
Sophi is here – Mobility, Simplicity, Safety, all combined in one device
Sophi is a revolutionary high-end surgical device which skillfully combines innovative concepts and newest technology. The benefits of Sophi facilitate simpler, safer and faster operating procedures which can lead to a significant increase in efficiency and economic benefits. Sophi is designed to bring you more flexibility and to improve the workflow in the operating room.
Discover LIBERTY® - Trifocal performance, complete spectacle independence & outstanding contrast sensitivity.
Medicontur’s patented EPS technology enables trifocality whilst leaving 75% of the lens surface refractive. What does this mean for your patient? Uncompromised visual acuity at all three distances (complete spectacle independence) and higher image quality (less dysphotopsia) - proven clinically in multiple studies.
Special Promotions
Images That Empower
Heidelberg Engineering burst onto the OCT scene back in 2007 with the SPECTRALIS® diagnostic imaging platform. Having explored the potential of swept-source OCT technology (SS-OCT) since 2011, the company entered into a patent license agreement in 2015, granting global and exclusive rights to 77 basic patents and patent applications which relate to SS-OCT technology and its application in ophthalmology.
> Read more
Upcoming Events
Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the eyecare industry – so why not take a look at our list of upcoming events?